98%
921
2 minutes
20
Background: The impact of nutritional supplements on weight gain in HIV-infected children on antiretroviral treatment (ART) remains uncertain. Starting supplements depends upon current weight-for-age or other acute malnutrition indicators, producing time-dependent confounding. However, weight-for-age at ART initiation may affect subsequent weight gain, independent of supplement use. Implications for marginal structural models (MSMs) with inverse probability of treatment weights (IPTW) are unclear.
Methods: In the ARROW trial, non-randomised supplement use and weight-for-age were recorded monthly from ART initiation. The effect of supplements on weight-for-age over the first year was estimated using generalised estimating equation MSMs with IPTW, both with and without interaction terms between baseline weight-for-age and time. Separately, data were simulated assuming no supplement effect, with use depending on current weight-for-age, and weight-for-age trajectory depending on baseline weight-for-age to investigate potential bias associated with different MSM specifications.
Results: In simulations, despite correctly specifying IPTW, omitting an interaction in the MSM between baseline weight-for-age and time produced increasingly biased estimates as associations between baseline weight-for-age and subsequent weight trajectory increased. Estimates were unbiased when the interaction between baseline weight-for-age and time was included, even if the data were simulated with no such interaction. In ARROW, without an interaction the estimated effect was +0.09 (95%CI +0.02,+0.16) greater weight-for-age gain per month's supplement use; this reduced to +0.03 (-0.04,+0.10) including the interaction.
Discussion: This study highlights a specific situation in which MSM model misspecification can occur and impact the resulting estimate. Since an interaction in the MSM (outcome) model does not bias the estimate of effect if the interaction does not exist, it may be advisable to include such a term when fitting MSMs for repeated measures.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347189 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0233877 | PLOS |
J Allergy Clin Immunol Pract
August 2025
Allergy, Immunology and Pediatric Pulmonary Institute,; Department of Pediatrics, Gray Faculty of Medical & Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
Background: Children with IgE-mediated food allergies, particularly milk, are at risk for hampered growth. Limited data is available regarding the benefit of oral immunotherapy (OIT) on growth outcomes.
Objectives: Evaluate the impact of OIT on growth metrics in this population.
PLOS Glob Public Health
August 2025
CURIE Study Consortium, Iganga-Mayuge Health and Demographic Surveillance System, Iganga, Makerere University, Uganda.
High malnutrition among children with CP in low-income countries underscores the need for community-based nutrition strategies. This study aimed to describe the effectiveness of two caregiver-led interventions including, the positive deviance (PD) and the parent facilitator training (PFT) interventions on malnutrition among children and youth (C&Y) with CP in rural Eastern Uganda. This was a 2x2 factorial quasi-randomized trial among 124 pairs of caregiver-malnourished C&Y with CP aged 2-24 years, at the Iganga Mayuge Health and Demographic Surveillance Site (IMHDSS) in Eastern Uganda.
View Article and Find Full Text PDFPLoS One
August 2025
Francis I Proctor Foundation, University of California, San Francisco, United States of America.
Background: In 2023, the World Health Organization (WHO) revised its guidelines for management of severe acute malnutrition (SAM). The revised guidelines include a focus on infants at risk of poor growth and development. The guideline identifies evaluation of routine antibiotics for these infants as a priority research area.
View Article and Find Full Text PDFBMJ Nutr Prev Health
January 2025
Nutrition and Planetary Health, MRC Unit The Gambia at LSHTM, Banjul, Fajara, Gambia.
Background: In a randomised placebo-controlled trial among exclusively breastfed rural Gambian infants aged 6-10 weeks at randomisation, daily iron supplementation for 14 weeks improved iron status. This secondary analysis explores the impact of iron supplementation on duration of exclusive breastfeeding and growth.
Methods: Breastfed 6-10 week-old infants were supplemented for 14 weeks with either daily iron or placebo (n=101).
Sci Rep
August 2025
Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, Tampere, 33014, Finland.
Asymptomatic malaria infections are common in endemic regions, yet their impact on children's growth remains inadequately understood. This study investigates the association between asymptomatic malaria and 6-18-month-old children's growth indices in rural Malawi. Dried blood spots from 840 participants in Lungwena Child Nutrition Intervention 5 (LCNI-5) clinical trial were analysed at the baseline (N = 697) and every 3 months for a year.
View Article and Find Full Text PDF